Table of Content

1 Immune Globulin Subcutaneous Market Overview
1.1 Product Overview and Scope of Immune Globulin Subcutaneous
1.2 Immune Globulin Subcutaneous Segment by Type
1.2.1 Global Immune Globulin Subcutaneous Market Value Comparison by Type (2024-2034)
1.2.2 2g
1.2.3 4g
1.2.4 10g
1.2.5 Other
1.3 Immune Globulin Subcutaneous Segment by Application
1.3.1 Global Immune Globulin Subcutaneous Market Value by Application: (2024-2034)
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Global Immune Globulin Subcutaneous Market Size Estimates and Forecasts
1.4.1 Global Immune Globulin Subcutaneous Revenue 2018-2029
1.4.2 Global Immune Globulin Subcutaneous Sales 2018-2029
1.4.3 Global Immune Globulin Subcutaneous Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Immune Globulin Subcutaneous Market Competition by Manufacturers
2.1 Global Immune Globulin Subcutaneous Sales Market Share by Manufacturers (2018-2024)
2.2 Global Immune Globulin Subcutaneous Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Immune Globulin Subcutaneous Average Price by Manufacturers (2018-2024)
2.4 Global Immune Globulin Subcutaneous Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Immune Globulin Subcutaneous, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Immune Globulin Subcutaneous, Product Type & Application
2.7 Immune Globulin Subcutaneous Market Competitive Situation and Trends
2.7.1 Immune Globulin Subcutaneous Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Immune Globulin Subcutaneous Players Market Share by Revenue
2.7.3 Global Immune Globulin Subcutaneous Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Immune Globulin Subcutaneous Retrospective Market Scenario by Region
3.1 Global Immune Globulin Subcutaneous Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Immune Globulin Subcutaneous Global Immune Globulin Subcutaneous Sales by Region: 2018-2029
3.2.1 Global Immune Globulin Subcutaneous Sales by Region: 2018-2024
3.2.2 Global Immune Globulin Subcutaneous Sales by Region: 2024-2029
3.3 Global Immune Globulin Subcutaneous Global Immune Globulin Subcutaneous Revenue by Region: 2018-2029
3.3.1 Global Immune Globulin Subcutaneous Revenue by Region: 2018-2024
3.3.2 Global Immune Globulin Subcutaneous Revenue by Region: 2024-2029
3.4 North America Immune Globulin Subcutaneous Market Facts & Figures by Country
3.4.1 North America Immune Globulin Subcutaneous Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Immune Globulin Subcutaneous Sales by Country (2018-2029)
3.4.3 North America Immune Globulin Subcutaneous Revenue by Country (2018-2029)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Immune Globulin Subcutaneous Market Facts & Figures by Country
3.5.1 Europe Immune Globulin Subcutaneous Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Immune Globulin Subcutaneous Sales by Country (2018-2029)
3.5.3 Europe Immune Globulin Subcutaneous Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Immune Globulin Subcutaneous Market Facts & Figures by Country
3.6.1 Asia Pacific Immune Globulin Subcutaneous Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Immune Globulin Subcutaneous Sales by Country (2018-2029)
3.6.3 Asia Pacific Immune Globulin Subcutaneous Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Immune Globulin Subcutaneous Market Facts & Figures by Country
3.7.1 Latin America Immune Globulin Subcutaneous Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Immune Globulin Subcutaneous Sales by Country (2018-2029)
3.7.3 Latin America Immune Globulin Subcutaneous Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Immune Globulin Subcutaneous Market Facts & Figures by Country
3.8.1 Middle East and Africa Immune Globulin Subcutaneous Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Immune Globulin Subcutaneous Sales by Country (2018-2029)
3.8.3 Middle East and Africa Immune Globulin Subcutaneous Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Immune Globulin Subcutaneous Sales by Type (2018-2029)
4.1.1 Global Immune Globulin Subcutaneous Sales by Type (2018-2024)
4.1.2 Global Immune Globulin Subcutaneous Sales by Type (2024-2029)
4.1.3 Global Immune Globulin Subcutaneous Sales Market Share by Type (2018-2029)
4.2 Global Immune Globulin Subcutaneous Revenue by Type (2018-2029)
4.2.1 Global Immune Globulin Subcutaneous Revenue by Type (2018-2024)
4.2.2 Global Immune Globulin Subcutaneous Revenue by Type (2024-2029)
4.2.3 Global Immune Globulin Subcutaneous Revenue Market Share by Type (2018-2029)
4.3 Global Immune Globulin Subcutaneous Price by Type (2018-2029)
5 Segment by Application
5.1 Global Immune Globulin Subcutaneous Sales by Application (2018-2029)
5.1.1 Global Immune Globulin Subcutaneous Sales by Application (2018-2024)
5.1.2 Global Immune Globulin Subcutaneous Sales by Application (2024-2029)
5.1.3 Global Immune Globulin Subcutaneous Sales Market Share by Application (2018-2029)
5.2 Global Immune Globulin Subcutaneous Revenue by Application (2018-2029)
5.2.1 Global Immune Globulin Subcutaneous Revenue by Application (2018-2024)
5.2.2 Global Immune Globulin Subcutaneous Revenue by Application (2024-2029)
5.2.3 Global Immune Globulin Subcutaneous Revenue Market Share by Application (2018-2029)
5.3 Global Immune Globulin Subcutaneous Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Immune Globulin Subcutaneous Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Takeda Immune Globulin Subcutaneous Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Immune Globulin Subcutaneous Sales, Revenue and Gross Margin (2018-2024)
6.2.4 CSL Immune Globulin Subcutaneous Product Portfolio
6.2.5 CSL Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Immune Globulin Subcutaneous Industry Chain Analysis
7.2 Immune Globulin Subcutaneous Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Immune Globulin Subcutaneous Production Mode & Process
7.4 Immune Globulin Subcutaneous Sales and Marketing
7.4.1 Immune Globulin Subcutaneous Sales Channels
7.4.2 Immune Globulin Subcutaneous Distributors
7.5 Immune Globulin Subcutaneous Customers
8 Immune Globulin Subcutaneous Market Dynamics
8.1 Immune Globulin Subcutaneous Industry Trends
8.2 Immune Globulin Subcutaneous Market Drivers
8.3 Immune Globulin Subcutaneous Market Challenges
8.4 Immune Globulin Subcutaneous Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Immune Globulin Subcutaneous Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Immune Globulin Subcutaneous Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Immune Globulin Subcutaneous Market Competitive Situation by Manufacturers in 2022
Table 4. Global Immune Globulin Subcutaneous Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Immune Globulin Subcutaneous Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Immune Globulin Subcutaneous Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Immune Globulin Subcutaneous Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Immune Globulin Subcutaneous Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Immune Globulin Subcutaneous, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Immune Globulin Subcutaneous, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Immune Globulin Subcutaneous, Product Type & Application
Table 12. Global Key Manufacturers of Immune Globulin Subcutaneous, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Immune Globulin Subcutaneous by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Globulin Subcutaneous as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Immune Globulin Subcutaneous Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Immune Globulin Subcutaneous Sales by Region (2018-2024) & (K Units)
Table 18. Global Immune Globulin Subcutaneous Sales Market Share by Region (2018-2024)
Table 19. Global Immune Globulin Subcutaneous Sales by Region (2024-2029) & (K Units)
Table 20. Global Immune Globulin Subcutaneous Sales Market Share by Region (2024-2029)
Table 21. Global Immune Globulin Subcutaneous Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Immune Globulin Subcutaneous Revenue Market Share by Region (2018-2024)
Table 23. Global Immune Globulin Subcutaneous Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Immune Globulin Subcutaneous Revenue Market Share by Region (2024-2029)
Table 25. North America Immune Globulin Subcutaneous Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Immune Globulin Subcutaneous Sales by Country (2018-2024) & (K Units)
Table 27. North America Immune Globulin Subcutaneous Sales by Country (2024-2029) & (K Units)
Table 28. North America Immune Globulin Subcutaneous Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Immune Globulin Subcutaneous Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Immune Globulin Subcutaneous Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Immune Globulin Subcutaneous Sales by Country (2018-2024) & (K Units)
Table 32. Europe Immune Globulin Subcutaneous Sales by Country (2024-2029) & (K Units)
Table 33. Europe Immune Globulin Subcutaneous Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Immune Globulin Subcutaneous Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Immune Globulin Subcutaneous Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Immune Globulin Subcutaneous Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Immune Globulin Subcutaneous Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Immune Globulin Subcutaneous Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Immune Globulin Subcutaneous Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Immune Globulin Subcutaneous Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Immune Globulin Subcutaneous Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Immune Globulin Subcutaneous Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Immune Globulin Subcutaneous Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Immune Globulin Subcutaneous Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Immune Globulin Subcutaneous Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Immune Globulin Subcutaneous Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Immune Globulin Subcutaneous Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Immune Globulin Subcutaneous Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Immune Globulin Subcutaneous Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Immune Globulin Subcutaneous Sales (K Units) by Type (2018-2024)
Table 51. Global Immune Globulin Subcutaneous Sales (K Units) by Type (2024-2029)
Table 52. Global Immune Globulin Subcutaneous Sales Market Share by Type (2018-2024)
Table 53. Global Immune Globulin Subcutaneous Sales Market Share by Type (2024-2029)
Table 54. Global Immune Globulin Subcutaneous Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Immune Globulin Subcutaneous Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Immune Globulin Subcutaneous Revenue Market Share by Type (2018-2024)
Table 57. Global Immune Globulin Subcutaneous Revenue Market Share by Type (2024-2029)
Table 58. Global Immune Globulin Subcutaneous Price (USD/Unit) by Type (2018-2024)
Table 59. Global Immune Globulin Subcutaneous Price (USD/Unit) by Type (2024-2029)
Table 60. Global Immune Globulin Subcutaneous Sales (K Units) by Application (2018-2024)
Table 61. Global Immune Globulin Subcutaneous Sales (K Units) by Application (2024-2029)
Table 62. Global Immune Globulin Subcutaneous Sales Market Share by Application (2018-2024)
Table 63. Global Immune Globulin Subcutaneous Sales Market Share by Application (2024-2029)
Table 64. Global Immune Globulin Subcutaneous Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Immune Globulin Subcutaneous Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Immune Globulin Subcutaneous Revenue Market Share by Application (2018-2024)
Table 67. Global Immune Globulin Subcutaneous Revenue Market Share by Application (2024-2029)
Table 68. Global Immune Globulin Subcutaneous Price (USD/Unit) by Application (2018-2024)
Table 69. Global Immune Globulin Subcutaneous Price (USD/Unit) by Application (2024-2029)
Table 70. Takeda Corporation Information
Table 71. Takeda Description and Business Overview
Table 72. Takeda Immune Globulin Subcutaneous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. Takeda Immune Globulin Subcutaneous Product
Table 74. Takeda Recent Developments/Updates
Table 75. CSL Corporation Information
Table 76. CSL Description and Business Overview
Table 77. CSL Immune Globulin Subcutaneous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 78. CSL Immune Globulin Subcutaneous Product
Table 79. CSL Recent Developments/Updates
Table 80. Key Raw Materials Lists
Table 81. Raw Materials Key Suppliers Lists
Table 82. Immune Globulin Subcutaneous Distributors List
Table 83. Immune Globulin Subcutaneous Customers List
Table 84. Immune Globulin Subcutaneous Market Trends
Table 85. Immune Globulin Subcutaneous Market Drivers
Table 86. Immune Globulin Subcutaneous Market Challenges
Table 87. Immune Globulin Subcutaneous Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Immune Globulin Subcutaneous
Figure 2. Global Immune Globulin Subcutaneous Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Immune Globulin Subcutaneous Market Share by Type in 2022 & 2029
Figure 4. 2g Product Picture
Figure 5. 4g Product Picture
Figure 6. 10g Product Picture
Figure 7. Other Product Picture
Figure 8. Global Immune Globulin Subcutaneous Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Immune Globulin Subcutaneous Market Share by Application in 2022 & 2029
Figure 10. Immunodeficiency
Figure 11. Autoimmune Disease
Figure 12. Acute Infection
Figure 13. Global Immune Globulin Subcutaneous Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Immune Globulin Subcutaneous Market Size (2018-2029) & (US$ Million)
Figure 15. Global Immune Globulin Subcutaneous Sales (2018-2029) & (K Units)
Figure 16. Global Immune Globulin Subcutaneous Average Price (USD/Unit) & (2018-2029)
Figure 17. Immune Globulin Subcutaneous Report Years Considered
Figure 18. Immune Globulin Subcutaneous Sales Share by Manufacturers in 2022
Figure 19. Global Immune Globulin Subcutaneous Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Immune Globulin Subcutaneous Players: Market Share by Revenue in 2022
Figure 21. Immune Globulin Subcutaneous Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Immune Globulin Subcutaneous Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Immune Globulin Subcutaneous Sales Market Share by Country (2018-2029)
Figure 24. North America Immune Globulin Subcutaneous Revenue Market Share by Country (2018-2029)
Figure 25. the United States Immune Globulin Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Immune Globulin Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Immune Globulin Subcutaneous Sales Market Share by Country (2018-2029)
Figure 28. Europe Immune Globulin Subcutaneous Revenue Market Share by Country (2018-2029)
Figure 29. Germany Immune Globulin Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Immune Globulin Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. UK Immune Globulin Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Immune Globulin Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Immune Globulin Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Immune Globulin Subcutaneous Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Immune Globulin Subcutaneous Revenue Market Share by Region (2018-2029)
Figure 36. China Immune Globulin Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Immune Globulin Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Immune Globulin Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Immune Globulin Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Immune Globulin Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan Immune Globulin Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Indonesia Immune Globulin Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Thailand Immune Globulin Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Malaysia Immune Globulin Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Immune Globulin Subcutaneous Sales Market Share by Country (2018-2029)
Figure 46. Latin America Immune Globulin Subcutaneous Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Immune Globulin Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Immune Globulin Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Immune Globulin Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Immune Globulin Subcutaneous Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Immune Globulin Subcutaneous Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Immune Globulin Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Immune Globulin Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. UAE Immune Globulin Subcutaneous Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Immune Globulin Subcutaneous by Type (2018-2029)
Figure 56. Global Revenue Market Share of Immune Globulin Subcutaneous by Type (2018-2029)
Figure 57. Global Immune Globulin Subcutaneous Price (USD/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Immune Globulin Subcutaneous by Application (2018-2029)
Figure 59. Global Revenue Market Share of Immune Globulin Subcutaneous by Application (2018-2029)
Figure 60. Global Immune Globulin Subcutaneous Price (USD/Unit) by Application (2018-2029)
Figure 61. Immune Globulin Subcutaneous Value Chain
Figure 62. Immune Globulin Subcutaneous Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed